Figure 3 | Scientific Reports

Figure 3

From: Machine learning insights into thrombo-ischemic risks and bleeding events through platelet lysophospholipids and acylcarnitine species

Figure 3

Patients with coronary artery disease and aberrant platelet lipid signatures are at increased risk to develop adverse cardiovascular events. Kaplan–Meier curves showing cluster-specific probability to develop adverse ischemic (A; ischemic stroke, myocardial infarction, CV death) or major bleeding events (B), respectively. Failure curves were significantly (p < 0.05) divergent between cluster groups. N = 595, mean follow-up 36 months, number of adverse ischemic events n = 25 and number of bleeding events n = 16.

Back to article page